SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,114,000 | -10.0% | 149,430 | +2.5% | 0.03% | +3.1% |
| Q2 2020 | $3,460,000 | +58.1% | 145,725 | +19.8% | 0.03% | +60.0% |
| Q1 2020 | $2,189,000 | -42.8% | 121,688 | -24.6% | 0.02% | -13.0% |
| Q4 2019 | $3,826,000 | +96.8% | 161,313 | +128.0% | 0.02% | +109.1% |
| Q3 2019 | $1,944,000 | -35.1% | 70,746 | -21.8% | 0.01% | -31.2% |
| Q2 2019 | $2,995,000 | +1.5% | 90,522 | +7.5% | 0.02% | +6.7% |
| Q1 2019 | $2,952,000 | +708.8% | 84,236 | +1061.7% | 0.02% | +650.0% |
| Q3 2018 | $365,000 | -14.1% | 7,251 | +2.2% | 0.00% | 0.0% |
| Q2 2018 | $425,000 | – | 7,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |